Specialty Pharmaceuticals
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
39
NCT01619150
A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2012
Completion: Jul 31, 2013
Loading map...